Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy

Research output: Contribution to journalArticleResearchpeer review

Authors

  • M. Aßmann
  • A. Stöbener
  • C. Mügge
  • S. K. Gaßmeyer
  • L. Hilterhaus
  • R. Kourist
  • A. Liese
  • S. Kara

External Research Organisations

  • Hamburg University of Technology (TUHH)
  • Ruhr-Universität Bochum
  • Graz University of Technology
View graph of relations

Details

Original languageEnglish
Pages (from-to)531-540
Number of pages10
JournalReaction Chemistry and Engineering
Volume2
Issue number4
Early online date19 May 2017
Publication statusPublished - Aug 2017
Externally publishedYes

Abstract

Biocatalytic (S)-naproxen synthesis using an (S)-selective arylmalonate decarboxylase mutant (AMDase G74C/M159L/C188G/V43I/A125P/V156L, AMDase-CLGIPL) exposes a promising environmentally friendly alternative to conventional chemical synthesis strategies. The reaction progress of naproxen synthesis catalyzed by AMDase-CLGIPL covalently immobilized onto a robust acrylate carrier was investigated with respect to reaction engineering. Kinetic characterization of the immobilized enzyme reveals a KM value of 22.1 ± 0.1 mM in the naproxen malonate conversion and an inhibiting effect of the produced naproxen with a Ki of 26.3 ± 1.4 mM. However, an effective process can be realized without in situ product removal yielding (S)-naproxen with an ee of 99%. By optimizing the product work-up, an isolated yield of 92% was achieved with total turnover numbers between 83,000 and 107,000 in five repetitive batches. Furthermore, process monitoring with in-line Raman spectroscopy was successfully applied to analyze the reaction progress with a root mean square error of prediction of 0.8 mM (corresponding to 4%).

ASJC Scopus subject areas

Cite this

Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy. / Aßmann, M.; Stöbener, A.; Mügge, C. et al.
In: Reaction Chemistry and Engineering, Vol. 2, No. 4, 08.2017, p. 531-540.

Research output: Contribution to journalArticleResearchpeer review

Aßmann, M, Stöbener, A, Mügge, C, Gaßmeyer, SK, Hilterhaus, L, Kourist, R, Liese, A & Kara, S 2017, 'Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy', Reaction Chemistry and Engineering, vol. 2, no. 4, pp. 531-540. https://doi.org/10.1039/c7re00043j
Aßmann, M., Stöbener, A., Mügge, C., Gaßmeyer, S. K., Hilterhaus, L., Kourist, R., Liese, A., & Kara, S. (2017). Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy. Reaction Chemistry and Engineering, 2(4), 531-540. https://doi.org/10.1039/c7re00043j
Aßmann M, Stöbener A, Mügge C, Gaßmeyer SK, Hilterhaus L, Kourist R et al. Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy. Reaction Chemistry and Engineering. 2017 Aug;2(4):531-540. Epub 2017 May 19. doi: 10.1039/c7re00043j
Aßmann, M. ; Stöbener, A. ; Mügge, C. et al. / Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy. In: Reaction Chemistry and Engineering. 2017 ; Vol. 2, No. 4. pp. 531-540.
Download
@article{59d73fbf3bc645bf803a7c383b6d99df,
title = "Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy",
abstract = "Biocatalytic (S)-naproxen synthesis using an (S)-selective arylmalonate decarboxylase mutant (AMDase G74C/M159L/C188G/V43I/A125P/V156L, AMDase-CLGIPL) exposes a promising environmentally friendly alternative to conventional chemical synthesis strategies. The reaction progress of naproxen synthesis catalyzed by AMDase-CLGIPL covalently immobilized onto a robust acrylate carrier was investigated with respect to reaction engineering. Kinetic characterization of the immobilized enzyme reveals a KM value of 22.1 ± 0.1 mM in the naproxen malonate conversion and an inhibiting effect of the produced naproxen with a Ki of 26.3 ± 1.4 mM. However, an effective process can be realized without in situ product removal yielding (S)-naproxen with an ee of 99%. By optimizing the product work-up, an isolated yield of 92% was achieved with total turnover numbers between 83,000 and 107,000 in five repetitive batches. Furthermore, process monitoring with in-line Raman spectroscopy was successfully applied to analyze the reaction progress with a root mean square error of prediction of 0.8 mM (corresponding to 4%).",
author = "M. A{\ss}mann and A. St{\"o}bener and C. M{\"u}gge and Ga{\ss}meyer, {S. K.} and L. Hilterhaus and R. Kourist and A. Liese and S. Kara",
note = "Funding Information: Financial support from the Deutsche Bundesstiftung Umwelt (DBU, eng. German Federal Environmental Foundation), grant no. AZ30818-32, is gratefully acknowledged. We thank Emil Bystr{\"o}m (SpinChem AB, Ume{\aa}, Sweden) for the kind provision of the rotating bed reactor, and Bj{\"o}rn Neuer and Prof. Dr. Gerrit A. Luinstra from the Institute of Technical and Macromolecular Chemistry (University of Hamburg) for 1H NMR purity analysis of (S)-naproxen. We thank tec5 AG (Oberursel, Germany) for providing the Raman spectrometer for the feasibility study and Tim Ramelow for performing the Raman measurements. ",
year = "2017",
month = aug,
doi = "10.1039/c7re00043j",
language = "English",
volume = "2",
pages = "531--540",
number = "4",

}

Download

TY - JOUR

T1 - Reaction engineering of biocatalytic (S)-naproxen synthesis integrating in-line process monitoring by Raman spectroscopy

AU - Aßmann, M.

AU - Stöbener, A.

AU - Mügge, C.

AU - Gaßmeyer, S. K.

AU - Hilterhaus, L.

AU - Kourist, R.

AU - Liese, A.

AU - Kara, S.

N1 - Funding Information: Financial support from the Deutsche Bundesstiftung Umwelt (DBU, eng. German Federal Environmental Foundation), grant no. AZ30818-32, is gratefully acknowledged. We thank Emil Byström (SpinChem AB, Umeå, Sweden) for the kind provision of the rotating bed reactor, and Björn Neuer and Prof. Dr. Gerrit A. Luinstra from the Institute of Technical and Macromolecular Chemistry (University of Hamburg) for 1H NMR purity analysis of (S)-naproxen. We thank tec5 AG (Oberursel, Germany) for providing the Raman spectrometer for the feasibility study and Tim Ramelow for performing the Raman measurements.

PY - 2017/8

Y1 - 2017/8

N2 - Biocatalytic (S)-naproxen synthesis using an (S)-selective arylmalonate decarboxylase mutant (AMDase G74C/M159L/C188G/V43I/A125P/V156L, AMDase-CLGIPL) exposes a promising environmentally friendly alternative to conventional chemical synthesis strategies. The reaction progress of naproxen synthesis catalyzed by AMDase-CLGIPL covalently immobilized onto a robust acrylate carrier was investigated with respect to reaction engineering. Kinetic characterization of the immobilized enzyme reveals a KM value of 22.1 ± 0.1 mM in the naproxen malonate conversion and an inhibiting effect of the produced naproxen with a Ki of 26.3 ± 1.4 mM. However, an effective process can be realized without in situ product removal yielding (S)-naproxen with an ee of 99%. By optimizing the product work-up, an isolated yield of 92% was achieved with total turnover numbers between 83,000 and 107,000 in five repetitive batches. Furthermore, process monitoring with in-line Raman spectroscopy was successfully applied to analyze the reaction progress with a root mean square error of prediction of 0.8 mM (corresponding to 4%).

AB - Biocatalytic (S)-naproxen synthesis using an (S)-selective arylmalonate decarboxylase mutant (AMDase G74C/M159L/C188G/V43I/A125P/V156L, AMDase-CLGIPL) exposes a promising environmentally friendly alternative to conventional chemical synthesis strategies. The reaction progress of naproxen synthesis catalyzed by AMDase-CLGIPL covalently immobilized onto a robust acrylate carrier was investigated with respect to reaction engineering. Kinetic characterization of the immobilized enzyme reveals a KM value of 22.1 ± 0.1 mM in the naproxen malonate conversion and an inhibiting effect of the produced naproxen with a Ki of 26.3 ± 1.4 mM. However, an effective process can be realized without in situ product removal yielding (S)-naproxen with an ee of 99%. By optimizing the product work-up, an isolated yield of 92% was achieved with total turnover numbers between 83,000 and 107,000 in five repetitive batches. Furthermore, process monitoring with in-line Raman spectroscopy was successfully applied to analyze the reaction progress with a root mean square error of prediction of 0.8 mM (corresponding to 4%).

UR - http://www.scopus.com/inward/record.url?scp=85051327242&partnerID=8YFLogxK

U2 - 10.1039/c7re00043j

DO - 10.1039/c7re00043j

M3 - Article

AN - SCOPUS:85051327242

VL - 2

SP - 531

EP - 540

JO - Reaction Chemistry and Engineering

JF - Reaction Chemistry and Engineering

IS - 4

ER -

By the same author(s)